Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Vaxart, Inc. (VXRT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $212.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $212.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $161.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $4.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $5.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $212.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $161.00K S-1 · filed 2026-05-08 | |
| 2025-12-31 | $4.00K S-1 · filed 2026-05-08 | |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $14.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $10.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $35.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $7.00K 10-Q · filed 2025-11-13 | $379.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-13 | $35.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.20M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $26.00K 10-K · filed 2024-03-14 | |
| 2023-09-30 | $44.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $40.00K 10-Q · filed 2023-08-03 | |
| 2022-12-31 | $133.00K 10-K · filed 2023-03-15 | |
| 2022-09-30 | $1.20M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.50M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $10.70M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $18.40M 10-K · filed 2022-02-24 | |
| 2021-09-30 | $20.10M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $18.10M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $11.30M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $21.60M 10-K · filed 2021-02-25 | |
| 2020-09-30 | $10.80M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $8.80M 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |